Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design
about
Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex.Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.Viral evasion and challenges of hepatitis C virus vaccine development.Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay.Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.Genome-wide analysis for identification of adaptive diversification between hepatitis C virus subtypes 1a and 1b.Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus.Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience.Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids.
P2860
Q33739145-9134842F-618A-4FBC-AA44-248D6B90C41BQ36246646-64257614-6773-4394-9055-02FD875C3047Q37144953-1E21DF98-314C-4778-8D3E-CD35BD4A8A42Q38715557-8158DA01-F6EF-45E8-9593-FC575A8EC97FQ38856649-DA122C96-232F-4736-BF7A-7FAB0D4A333FQ38961608-9EC666F6-FFD5-4EE0-B823-3359AF869FE1Q39148859-B7FF6955-F036-46A6-B61A-2B2D16F17C34Q39301797-E0213C9B-E457-448C-93BE-F76E88BE33E1Q40098163-6216C06D-5FDE-460C-85F2-43DA0D54FD17Q40141933-A96B0F85-FAAE-40BC-9106-9B0AE117C08EQ40382054-79643B1A-9268-4930-8552-F44A89720252Q40634075-5E4AAE45-C5ED-46A0-ADA3-780F395ECB21Q40711741-026D3904-08DD-4BC1-85DE-B17FFCBE600BQ47548062-5F5CF65C-F433-4684-B77C-E9424E7BB310Q47564117-9D1DE43B-D834-4C8B-A439-A1B0696EBF1FQ55256500-7C739D9D-3137-444A-8360-2440AEA630A1
P2860
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@ast
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@en
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@nl
type
label
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@ast
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@en
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@nl
prefLabel
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@ast
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@en
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Genetic Diversity Underlying t ...... mplications for Vaccine Design
@en
P2093
Julie Sheldon
Kathrin Hueging
Tanvi Khera
P2860
P304
P3181
P356
10.3390/V7072809
P407
P5008
P577
2015-07-01T00:00:00Z
2015-07-17T00:00:00Z